Patent Boutique Llp opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Patent Boutique Llp

Patent Number:
Title:
Toxicity Management For Anti-Tumor Activity Of Cars
Opposition Date:
Sep 28, 2023
Patent Number:
Title:
Treatment Of Cancer Using Chimeric Antigen Receptor
Applicant:
Opposition Date:
Sep 14, 2023
Patent Number:
Title:
Methods For Enhancing Efficacy Of Therapeutic Immune Cells
Opposition Date:
Mar 21, 2023
Patent Number:
Title:
Chimeric Antigen Receptors (Cars) Targeting Hematologic Malignancies, Compositions And Methods Of Use Thereof
Applicant:
Opposition Date:
Feb 3, 2023
Patent Number:
Title:
Subcutaneous Formulations Of Anti-Cd38 Antibodies And Their Uses
Opposition Date:
Dec 29, 2022
Patent Number:
Title:
Anti-Pd-L1 Combinations For Treating Tumors
Opposition Date:
Nov 23, 2022
Patent Number:
Title:
Immunoglobulin Variable Domains
Applicant:
Opposition Date:
Oct 25, 2022
Patent Number:
Title:
Ribonucleic Acids Containing N1-Methyl-Pseudouracils And Uses Thereof
Applicant:
Opposition Date:
Sep 27, 2022
Patent Number:
Title:
Early Intervention Methods To Prevent Or Ameliorate Toxicity
Opposition Date:
Sep 22, 2022
Patent Number:
Title:
Composition For Cleaving A Target Dna Comprising A Guide Rna Specific For The Target Dna And Cas Protein-Encoding Nucleic Acid Or Cas Protein, And Use Thereof
Opposition Date:
Sep 7, 2022

Want to track Patent Boutique Llp?

Feel free to send us a message here and we will get back to you